Table III.
CSDAP1 | ||||||
---|---|---|---|---|---|---|
Parameters | n | % | High expression | Low expression | χ2 value | P-value |
Sex | 0.09 | 0.764 | ||||
Male | 219 | 38.4 | 84 | 135 | ||
Female | 58 | 36.2 | 21 | 37 | ||
Age (years) | 0.461 | 0.794 | ||||
≤40 | 49 | 36.7 | 18 | 31 | ||
40–60 | 113 | 33.6 | 38 | 75 | ||
>60 | 155 | 31.6 | 49 | 106 | ||
Diameter of tumors | 0.683 | 0.409 | ||||
≤3 cm | 128 | 30.5 | 39 | 89 | ||
>3 cm | 189 | 34.9 | 66 | 123 | ||
Differentiation degree | 3.387 | 0.066 | ||||
Middle and high differentiation | 147 | 27.9 | 41 | 106 | ||
Low (non) differentiation | 170 | 37.6 | 64 | 106 | ||
Types of tissues | 7.742 | 0.005 | ||||
Pulmonary adenocarcinoma | 138 | 42.8 | 59 | 79 | ||
Lung squamous cell carcinoma | 167 | 27.5 | 46 | 121a | ||
Lymph node metastasis | 7.09 | 0.008 | ||||
Yes | 127 | 41.7 | 53 | 74 | ||
No | 190 | 27.4 | 52 | 138 | ||
Clinical staging | 11.83 | 0.001 | ||||
I–II | 179 | 25.1 | 45 | 134 | ||
III–IV | 138 | 43.5 | 60 | 78 |
Compared with the High expression group. P<0.05.